CVS Caremark decided to stop offering Zepbound in favor of Wegovy for weight loss. It’s the latest example of limits imposed ...

Eli Lilly's weight-loss jab Mounjaro has been cleared for rollout by the NHS in England, with around 3.4 million people eligible, but will be made available in stages to limit the financial impact.

The life sciences industry is in a position to help humanity, perhaps more than ever, with the introduction of generative AI (GenAI). Lengthy drug development timelines and complex regulatory ...